Open-Label, Extension Study to 810P202
NCT01416064
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
78
Enrollment
INDUSTRY
Sponsor class
Conditions
Impulsive Aggression Comorbid With ADHD in Children
Interventions
DRUG:
Molindone
Sponsor
Supernus Pharmaceuticals, Inc.